Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study

被引:0
|
作者
Shuai Yuan
Jie Chen
Xue Li
Rongrong Fan
Benoit Arsenault
Dipender Gill
Edward L. Giovannucci
Ju-sheng Zheng
Susanna C. Larsson
机构
[1] Karolinska Institutet,Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine
[2] Zhejiang University School of Medicine,Centre for Global Health
[3] Central South University,Department of Gastroenterology, The Third Xiangya Hospital
[4] Zhejiang University School of Medicine,School of Public Health and the Second Affiliated Hospital
[5] University of Edinburgh,Centre for Global Health, Usher Institute
[6] Karolinska Institutet,Department of Biosciences and Nutrition
[7] Centre de Recherche de l’Institut Universitaire de Cardiologie et de Pneumologie de Québec,Department of Medicine, Faculty of Medicine
[8] Université Laval,Department of Epidemiology and Biostatistics, School of Public Health
[9] Imperial College London,Clinical Pharmacology and Therapeutics Section, Institute for Infection and Immunity, St George’s
[10] University of London,Clinical Pharmacology Group, Pharmacy and Medicines Directorate
[11] St George’s University Hospitals NHS Foundation Trust,Department of Epidemiology
[12] Novo Nordisk Research Centre Oxford,Department of Nutrition
[13] Harvard T H Chan School of Public Health,Key Laboratory of Growth Regulation and Translational Research of Zhejiang Province, School of Life Sciences
[14] Harvard T H Chan School of Public Health,Department of Surgical Sciences
[15] Westlake University,undefined
[16] Uppsala University,undefined
来源
关键词
Lifestyle; Mendelian randomization; Metabolic factor; Nonalcoholic fatty liver disease;
D O I
暂无
中图分类号
学科分类号
摘要
The risk factors for nonalcoholic fatty liver disease (NAFLD) have not been clearly identified. We conducted a Mendelian randomization (MR) study to explore this. Independent genetic variants strongly associated with 5 lifestyle and 9 metabolic factors were selected as instrumental variables from corresponding genome-wide association studies (GWASs). Summary-level data for NAFLD were obtained from a GWAS meta-analysis of 8434 cases and 770,180 non-cases (discovery dataset) and another GWAS meta-analysis of 1483 cases and 17,781 non-cases (replication dataset). Univariable and multivariable MR analyses were performed. There were associations with NAFLD for lifetime smoking index (odds ratio (OR) 1.59, 95% confidence interval (CI) 1.31–1.93 per SD-increase), body mass index (BMI, OR 1.33, 95% CI 1.23–1.43 per SD-increase), waist circumference (OR 1.82; 95% CI 1.48–2.24 per SD-increase), type 2 diabetes (OR 1.21, 95% CI 1.15–1.27 per unit increase in log-transformed odds), systolic blood pressure (OR 1.17; 95% CI 1.07–1.26 per 10 mmHg increase), high-density lipoprotein cholesterol (OR 0.84, 95% CI 0.77–0.90 per SD-increase), and triglycerides (OR 1.23, 95% CI 1.15–1.33 per SD-increase). The associations for type 2 diabetes, systolic blood pressure, triglycerides, but not for high-density lipoprotein cholesterol remained strong after adjusting for genetically-predicted BMI. Genetic liability to type 2 diabetes mediated 51.4% (95% CI 13.4–89.3%) of the BMI-effects on NAFLD risk. There were suggestive inverse associations of genetically-predicted alcohol, coffee, and caffeine consumption, and vigorous physical activity with NAFLD risk. This study identified several lifestyle and metabolic factors that may be causally implicated in NAFLD.
引用
收藏
页码:723 / 733
页数:10
相关论文
共 50 条
  • [1] Lifestyle and metabolic factors for nonalcoholic fatty liver disease: Mendelian randomization study
    Yuan, Shuai
    Chen, Jie
    Li, Xue
    Fan, Rongrong
    Arsenault, Benoit
    Gill, Dipender
    Giovannucci, Edward L.
    Zheng, Ju-Sheng
    Larsson, Susanna C.
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2022, 37 (07) : 723 - 733
  • [2] A Mendelian randomization study Years of education and nonalcoholic fatty liver disease
    Chen, Jun
    Li, Jing
    Qu, Hongyan
    Ning, Ting
    Xie, Haoyuan
    Lu, Gang
    [J]. MEDICINE, 2024, 103 (27)
  • [3] Effects of homocysteine on nonalcoholic fatty liver related disease: A mendelian randomization study
    Chen, Pengcheng
    Yang, Ze
    Guo, Lingyun
    Huang, Yingfei
    Li, Jingjia
    Chen, Xin
    [J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [4] The associations between modifiable risk factors and nonalcoholic fatty liver disease: A comprehensive Mendelian randomization study
    Xie, Jiarong
    Huang, Hangkai
    Liu, Zhening
    Li, Youming
    Yu, Chaohui
    Xu, Lei
    Xu, Chengfu
    [J]. HEPATOLOGY, 2023, 77 (03) : 949 - 964
  • [5] Nonalcoholic fatty liver disease and type 2 diabetes: an observational and Mendelian randomization study
    Yu, Yuetian
    Yu, Yuefeng
    Wang, Yuying
    Chen, Yi
    Wang, Ningjian
    Wang, Bin
    Lu, Yingli
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [6] Causal effects from nonalcoholic fatty liver disease on cholelithiasis: A mendelian randomization study
    Su, Yin-Shi
    Lin, Shuang-Zhe
    Chen, Yuan-Wen
    [J]. HEALTH SCIENCE REPORTS, 2024, 7 (03)
  • [7] Visceral adipose tissue and risk of nonalcoholic fatty liver disease: A Mendelian randomization study
    Tao, Min
    Zhou, Guanghong
    Liu, Jing
    He, Miao
    Wang, Cong
    Luo, Xie
    Zhang, Lili
    [J]. CLINICAL ENDOCRINOLOGY, 2023, 99 (04) : 370 - 377
  • [8] Diet-derived antioxidants and nonalcoholic fatty liver disease: a Mendelian randomization study
    Chen, Lanlan
    Fan, Zhongqi
    Sun, Xiaodong
    Qiu, Wei
    Mu, Wentao
    Chai, Kaiyuan
    Cao, Yannan
    Wang, Guangyi
    Lv, Guoyue
    [J]. HEPATOLOGY INTERNATIONAL, 2023, 17 (02) : 326 - 338
  • [9] Genetically Regulated Bilirubin and Risk of Nonalcoholic Fatty Liver Disease: A Mendelian Randomization Study
    Luo, Lei
    An, Ping
    Jia, Xinyong
    Yue, Xiaobian
    Zheng, Sujun
    Liu, Shuang
    Chen, Yu
    Winkler, Cheryl A.
    Duan, Zhongping
    [J]. HEPATOLOGY, 2018, 68 : 1300A - 1300A
  • [10] Diet-derived antioxidants and nonalcoholic fatty liver disease: a Mendelian randomization study
    Lanlan Chen
    Zhongqi Fan
    Xiaodong Sun
    Wei Qiu
    Wentao Mu
    Kaiyuan Chai
    Yannan Cao
    Guangyi Wang
    Guoyue Lv
    [J]. Hepatology International, 2023, 17 : 326 - 338